Loading...
 
Toggle Health Problems and D

Global vitamin D clinical trials, table of contents of commercial report – Aug 2013

Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2013

http://www.reportlinker.com/p0941755/Vitamin-D-Deficiency-Disorders-Global-Clinical-Trials-Review-H2-2013.html
NEW YORK, Aug. 22, 2013 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:
$2,500!

Summary

GlobalData's clinical trial report, "Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2013" provides data on the Vitamin D Deficiency Disorders clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vitamin D Deficiency Disorders. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vitamin D Deficiency Disorders. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2

List of Tables 4
List of Figures 6
Introduction 7
Vitamin D Deficiency Disorders 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Vitamin D Deficiency Disorders 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Vitamin D Deficiency Disorders Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Merck & Co., Inc. 33
Clinical Trial Overview of Merck & Co., Inc. 33
Cytochroma Inc. 34
Clinical Trial Overview of Cytochroma Inc. 34
Kyowa Hakko Kirin Pharma, Inc. 35
Clinical Trial Overview of Kyowa Hakko Kirin Pharma, Inc. 35
Pharma Patent Kft. 36
Clinical Trial Overview of Pharma Patent Kft. 36
Clalit Health Services 37
Clinical Trial Overview of Clalit Health Services 37
S:t Eriks Ogonsjukhus AB 38
Clinical Trial Overview of S:t Eriks Ogonsjukhus AB 38
Laboratoires S.M.B. 39
Clinical Trial Overview of Laboratoires S.M.B. 39
DSM Nutritional Products AG 40
Clinical Trial Overview of DSM Nutritional Products AG 40
Abbott Laboratories 41
Clinical Trial Overview of Abbott Laboratories 41
Zeria Pharmaceutical Co Ltd 42
Clinical Trial Overview of Zeria Pharmaceutical Co Ltd 42
Teva Pharmaceutical Industries Limited 43
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 43
Takeda Pharmaceutical Company Limited 44
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 44
Clinical Trial Overview of Top Institutes / Government 45
University of Wisconsin Madison 45
Clinical Trial Overview of University of Wisconsin Madison 45
Creighton University 46
Clinical Trial Overview of Creighton University 46
The Medical University of Graz 47
Clinical Trial Overview of The Medical University of Graz 47
Massachusetts General Hospital 48
Clinical Trial Overview of Massachusetts General Hospital 48
University of Alabama at Birmingham 49
Clinical Trial Overview of University of Alabama at Birmingham 49
Tufts University 50
Clinical Trial Overview of Tufts University 50
Rambam Health Care Campus 51
Clinical Trial Overview of Rambam Health Care Campus 51
Aarhus University 52
Clinical Trial Overview of Aarhus University 52
Winthrop-University Hospital 53
Clinical Trial Overview of Winthrop-University Hospital 53
Boston Medical Center 54
Clinical Trial Overview of Boston Medical Center 54
Medical University of South Carolina 55
Clinical Trial Overview of Medical University of South Carolina 55
Martin-Luther-Universitat Halle-Wittenberg 56
Clinical Trial Overview of Martin-Luther-Universitat Halle-Wittenberg 56
Mayo Clinic 57
Clinical Trial Overview of Mayo Clinic 57
McGill University 58
Clinical Trial Overview of McGill University 58
U.S. Department of Veterans Affairs 59
Clinical Trial Overview of U.S. Department of Veterans Affairs 59
University of Massachusetts 60
Clinical Trial Overview of University of Massachusetts 60
University of California, Los Angeles 61
Clinical Trial Overview of University of California, Los Angeles 61
Columbia University 62
Clinical Trial Overview of Columbia University 62
University of Toronto 63
Clinical Trial Overview of University of Toronto 63
University of Nebraska 64
Clinical Trial Overview of University of Nebraska 64
Five Key Clinical Profiles 65
Appendix 85
Abbreviations 85
Definitions 85
Research Methodology 86
Secondary Research 86
About GlobalData 87
Contact Us 87
Disclaimer 87
Source 88

List of Tables

  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 15
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, BRIC Countries, 2013* 16
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, G7 Countries, 2013* 17
  • Vitamin D Deficiency Disorders Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, E7 Countries, 2013* 19
  • Vitamin D Deficiency Disorders Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 33
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytochroma Inc., 2013* 34
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyowa Hakko Kirin Pharma, Inc., 2013* 35
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharma Patent Kft., 2013* 36
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Clalit Health Services, 2013* 37
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by S:t Eriks Ogonsjukhus AB, 2013* 38
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires S.M.B., 2013* 39
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by DSM Nutritional Products AG, 2013* 40
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2013* 41
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeria Pharmaceutical Co Ltd, 2013* 42
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2013* 43
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2013* 44
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2013* 45
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Creighton University, 2013* 46
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2013* 47
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2013* 48
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2013* 49
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts University, 2013* 50
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2013* 51
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2013* 52
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Winthrop-University Hospital, 2013* 53
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Medical Center, 2013* 54
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2013* 55
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Martin-Luther-Universitat Halle-Wittenberg, 2013* 56
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 57
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University, 2013* 58
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013* 59
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2013* 60
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2013* 61
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2013* 62
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2013* 63
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2013* 64

List of Figures

  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 15
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
  • Vitamin D Deficiency Disorders Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
  • Vitamin D Deficiency Disorders Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
  • Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
  • Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
  • GlobalData Methodology 86

See also VitaminDWiki

Surf to   is.gd/proofvitd   for updates or details
Select pink box in the upper right to select a language
Click on underlined items for details

Dec 2016 PDFs of this page (with 75 proofs) in
No such attachment on this page  No such attachment on this page  No such attachment on this page  No such attachment on this page  No such attachment on this page  No such attachment on this page   No such attachment on this page  No such attachment on this page

Health Problem Treat
Prevent
Reduction by Vit DRCT = Randomized Controlled Trial
   * = link to additional RCT
CT = Clinical Trial
HypertensionT
P
149 to 142 mm Hg
HT risk reduced 10X
RCT*  *, 2400 IU.  100,000 IU*
When Vitamin D > 40 ng
Cardiovascular after attack T 32 % fewer deaths CT 1000 IU
Diabetes Type 1 P 85 % 12,000 kids, 2000 IU
Diabetes Type 2T 62 % RCT* CRP reduction, 4000 IU
Injection is far better - RCT *
RCT 50,000 IU/2weeks + probiotics
RCT 5,000 IU daily 6 months
Back Pain T 95 %
reduced 50%
5000/10000 IU
60,000 IU weekly
Influenza P 90 % RCT *, 2000 IU
Falls P 50%RCT, 100,000 IU monthly
RCT with Meals on Wheels 2016
Hip Fractures P 30 % RCT * 800 IU
Rickets P 98 % Turkey, 400 IU
NOT RCT, given to all children
Raynaud's Syndrome T 40 % RCT, visual scale, 20000 IU Avg
Menstrual pain P 76 % RCT, 7000 IU Avg,
70% reduction 2018
PMS reduced by half
Pregnancy risks P 50 % RCT, 4000 IU
C-section, unplanned P 50 % RCT, 4000 IU, small study
Low birth weight P 60 % RCT * 1000 IU of D2
TBP 60 % RCT, 800 IU
Breast Cancer P 60 % RCT, 1100 IU (2007)
Rheumatoid Arthritis pain T 40 % RCT, 500 IU, added to prescription
Cystic Fibrosis T 75 %
2nd study improved
RCT, pilot 4X fewer deaths 250,000 IU
RCT, pilot 8,200 IU
Chronic Kidney T 90 to 70 PTH RCT, 3500 IU,
Respiratory Tract Infection P 63 % 3 RCT, 4000 IU 1 year 2nd 2000/800 IU
20,000 IU weekly
Lupus T
T
zero flares
Pain reduced
Loading then 100,000 IU monthly,
RCT too
RCT 4,000 IU
Sickle Cell T Less pain
RCT, up to 100,000 IU/week
Leg ulcer healing T 4X faster RCT, 50,0000 IU/week, small study
Traumatic Brain Injury T 2X RCT, 20,0000 IU/day with progesterone
Parkinson's DiseaseT StabilizedRCT, 1200 IU/day
Multiple SclerosisP
T
68%
95% were CURED
RCT, 7100 IU prevent pre-MS ==> MS
20,000 to 140,000 IU/day
Congestive Heart Failure T 90 % RCT, 1000 IU infants (also: Adults, not RCT)
Middle Ear Infection P 30 % RCT, 1000 IU infants
GingivitisT 88 %RCT, 2000 IU
Muscle in seniors T 17 % more muscle RCT, 4000 IU
Antibiotic use when >70y T 47 % RCT, 60,000 IU monthly
Infants tallerBenefit1 cm tall RCT, 50,000 IU weekly,
for 8 weeks while pregnant
Gestational Diabetes T Reduced 3X RCT, 2 doses of 50,000 IU
After Heart Attack T +6% ejection fraction RCT, 800,000 IU one time
Prostate Cancer T Fewer +cores RCT, 4000 IU (2012)
Asthma P   T Reduced symptoms RCT, 60K IU/month;
RCT 50K IU/week
Need good D at 4 weeks into preg.
Depression T Reduced RCT 300,000 IU injection
RCT 1500 IU helped Prozac
RCT 50,000 IU weekly, elderly
Low vitamin D
while breastfed
P All infants > 20 mg RCT, 5,000 IU
Fibromyalgia T Half of many still has FibroRCT, 30-48 ng
RCT 50K IU/week
Hives, Chronic T Reduced 40% RCT, 4000 IU added
CholesterolT Reduced 4 mg RCT, 400 IU + Ca
Weight Loss T lost 5 more lbs RCT, 2000 IU +diet +exercise
Gestational DiabetesP 40% RCT * , 5,000 IU
Chronic Obstructive
Pulmonary Disease
T 17X improvement CT, 50,000 IU weekly
RCT 100,000 IU monthly
Asthma T 1/2 Asthma attacks RCT >42 mg of vitamin D
Quality of Life (QoL) T Nursing Home QoL CT, 4,000 IU in daily bread
Death of Critically Ill
Patients
T 20% increase in survivability RCT 540 K IU loading than 90K monthly
Restless Leg Syndrome T Score 26 ==> 10 CT, Vitamin D dose size
not stated in abstract
Hepatitis-C T Aided normal drugs RCT 2.000 IU
Crohn's disease T improved when > 30 ng
2nd study fewer relapses
RCT 2,000 IU
10,000 IU RCT
Pre-term birth P 2.5X decrease, also: fewer
c-section & better Apgar
RCT 2,000 IU India
Cluster headaches T CH eliminated in 60% 10,000 IU, Mg, Omega-3, etc
Autism T 80% improved CT 300 IU/kg/day for 3 months
PreDiabetes T ~20% reduced RCT 60,000 IU/month
Weight loss:
Overweight and Obese
T 12 lbs in 6 months RCT 100,000 IU/month
Sarcopenia = muscle loss T 27% increase RCT 1,000 IU
Growing Pains T 60% decrease ~100,000 IU/month -NOT RCT
2nd study, similar results
Osteoarthritis pain T 60% decrease 50,000 IU/weekly - NOT RCT
ALS T helped 2,000 IU - NOT RCT, given to all
Vertigo T 3X reduction if raised > 10ng 600,000 IU load, then maint.
NOT RCT, given to all
Warts T 80% eliminated injection NOT RCT
60,000 IU/injection
Metabolic Syndrome P reduced 44% when VitD
increased by 30 ng
NOT RCT, given to all
Hay fever P reduced 48% RCT   1,000 IU for 30 days
Preeclampsia P Recurrance cut in half
3 RCT 3.6 X less likely if > 30 ng
50,000 IU every 2 weeks
4,000 IU daily
Blood cell cancer
Multiple Myeloma
T Survival 90% vs 50%10,000 IU/week
NOT RCT, given to all
Irritable Bowel Syndrome T Reduced3,000 IU spray RCT
Urinary Tract Infection P 50% reduction RCT 20,000 IU weekly
Mite Allergy P 5X reductionRCT 2,000 IU preg, 800 IU child
Perinatal depression
(depression near birth)
T 50% reduction RCT 2,000 IU for just a few weeks
Vaginosis T 10X reductionRCT 2,000 IU
Eczema T Reduced2 RCT 1,600 IU
Non-Alcoholic
Fatty Liver Disease
T Reduced RCT 20,000 IU weekly
Knee Osteoartiritis T Pain Reduced RCT 60,000 IU monthly after loading dose
Tuberculosis T Faster Recovery RCT single 450,000 IU dose
Stroke - Ischemic T Faster Recovery RCT single 600,000 IU injection
RCT single 300,000 IU injection
Sepsis T Reduce ICU and Hospital
length of stay by 7 days each
RCT 400,000 IU
Trauma deaths T 50% fewer deaths Vitamin D & Glutamine
NOT RCT, given to all
Hemodialysis patients T helped 50,000 IU weekly NOT RCT, given to all
Fatty liver - child T 2 X reduction RCT  Vitamin D & DHA
Fatigue T Reduced 100,000 IU single dose
NOT RCT, given to all
Sleep Disorders T Nicely treated RCT  50.000 IU bi-weekly
Pneumonia
(Ventilator-associated)
T RCT   Death rate cut in half300,000 IU injection
Infertile males T birth rate doubled RCT   300,000 IU + maint
Waist size T Waist size reduced 3 cm 100,000 IU loading + maint for 6 months
for those with Metabolic Syndrome
NOT RCT, given to all
Attention Deficient
Hyperactivity Disorder
T Reduced
Reduced
RCT  3,000 IU for 12 weeks
RCT  50,000 IU weekly
Alcoholic liver cirrhosis T improved survival1,000 IU of vitamin D NOT RCT
Diabetic nephropathy T Reduced HOMA-IR, FRS RCT 50,000 IU weekly
Ulcerative Colitis T Reduced 60% RCT 50,000 IU nano daily for a week
Obese weight loss T Lost 3X more pounds $10 of Vitamin D added to
  calorie restriction & walking
Endometriosis T Nicely treated RCT  50.000 IU bi-weekly
Diabetic Wounds T 4X more likely to heal RCT  6,400 daily
See any problem with this page? Report it (FINALLY WORKS)